Breaking News Instant updates and real-time market news.

MAR

Marriott

$121.78

-0.38 (-0.31%)

06:28
11/30/18
11/30
06:28
11/30/18
06:28

Marriott down 5.6% after announcing data breach

  • 30

    Nov

  • 05

    Dec

MAR Marriott
$121.78

-0.38 (-0.31%)

11/27/18
11/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from In-Line at Imperial Capital with analyst David Miller saying while fiscal 2019 should be a "transitional year," fiscal 2020 brings an "abundance of catalysts." 2. Citizens Financial (CFG) upgraded to Outperform from Neutral at Macquarie. 3. Parsley Energy (PE) upgraded to Buy from Neutral at Goldman Sachs with analyst John Nelson saying greater appreciation of the the company's free cash flow inflection in the second half of 2019 should drive improved investor sentiment. 4. Taubman Centers (TCO) was upgraded to Sector Perform from Underperform at Scotiabank and to Equal Weight from Underweight at Morgan Stanley. 5. Marriott (MAR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Stephen Grambling saying the stock has been penalized recently amid Starwood integration issues, but these will prove temporary and position Marriott better in the future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/27/18
GSCO
11/27/18
DOWNGRADE
Target $70
GSCO
Buy
Wyndham Hotels & Resorts downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Stephen Grambling removed Wyndham Hotels & Resorts (WYN) from his firm's America's Conviction List while keeping a Buy rating on the shares. The analyst lowered his price target for the stock to $70 from $76. Grambling reduced his estimates for Wyndham to reflect incremental caution around timeshare amid softening housing data and rising rates. However, he continues to believe upside from the La Quinta acquisition, accelerating unit growth, and fee rates should all drive upside to consensus estimates and a "re-rating" versus peers. Nonetheless, Grambling sees a more attractive risk/reward in shares of Marriott (MAR).
11/27/18
GSCO
11/27/18
UPGRADE
GSCO
Conviction Buy
Marriott upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Stephen Grambling added Marriott International to his firm's America's Conviction List while keeping a Buy rating on the shares. The analyst lowered his price target for the shares to $153 from $159. The stock has been penalized recently amid Starwood integration issues, but these will prove temporary and position Marriott better in the future, Grambling tells investors in a research note. He believes that as the disruption normalizes, net unit growth should accelerate and Marriott should post upside to consensus estimates.
11/20/18
ARGS
11/20/18
DOWNGRADE
ARGS
Hold
Marriott downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded Marriott (MAR) to Hold, citing a recent slowdown in its RevPAR growth as well as the potential for the multi-year upturn in the lodging industry to end. The analyst states that the company's latest EPS beat reflected stock repurchases and "carefully managed expenses", as revenue fell 1% and North America RevPAR was up just 0.6% and below the management's prior guidance of 1.5%-2.0% growth. Staszak adds that Marriott shares have rallied over 200% since his upgrade in 2012, but believes that other consumer discretionary names such as McDonalds (MCD) offer greater return prospects.

TODAY'S FREE FLY STORIES

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

, AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

13:59
12/12/19
12/12
13:59
12/12/19
13:59
Recommendations
TherapeuticsMD, Amneal Pharmaceuticals, Merck analyst commentary  »

Stifel says…

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

MRK

Merck

$89.27

0.31 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

HURN

Huron

$69.15

0.23 (0.33%)

13:57
12/12/19
12/12
13:57
12/12/19
13:57
Conference/Events
Huron management to meet with Benchmark »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

13:55
12/12/19
12/12
13:55
12/12/19
13:55
Conference/Events
The FDIC to hold a Board Meeting »

Board of Directors…

MLNT

Melinta Therapeutics

$1.71

0.15 (9.62%)

13:48
12/12/19
12/12
13:48
12/12/19
13:48
Hot Stocks
FDA approves Melinta Therapeutics sNDA for Orbactiv for injection »

A letter posted by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$122.30

-0.08 (-0.07%)

13:45
12/12/19
12/12
13:45
12/12/19
13:45
Options
TakeTwo Interactive Software call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

KW

Kennedy Wilson

$22.26

-0.25 (-1.11%)

13:44
12/12/19
12/12
13:44
12/12/19
13:44
Hot Stocks
Kennedy Wilson raises quarterly dividend 5% to 22c per share »

Kennedy Wilson announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

, SPX

S&P 500

$0.00

(0.00%)

13:38
12/12/19
12/12
13:38
12/12/19
13:38
Periodicals
WH Press Secretary says President to hold trade meeting at 2:30, CNBC reports »

CNBC political reporter…

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$67.62

0.48 (0.71%)

13:36
12/12/19
12/12
13:36
12/12/19
13:36
Periodicals
PrEP4All says USPTO adviser showed 'bias' in favor of Gilead, STAT reports »

An AIDS activist group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$8.98

0.01 (0.11%)

13:35
12/12/19
12/12
13:35
12/12/19
13:35
Options
Barclays put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.37

0.385 (3.51%)

13:20
12/12/19
12/12
13:20
12/12/19
13:20
Options
Largest trade of the day is a Jan 2021 GE 1x3 totalling 108K contracts »

Largest trade of the day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

13:20
12/12/19
12/12
13:20
12/12/19
13:20
General news
Treasury's $16 B 30-year bond reopening was very, very well received »

Treasury's $16 B…

HIIQ

Health Insurance Innovations

$19.23

0.88 (4.80%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/12/19
12/12
13:16
12/12/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Coupon Rate data reported »

30-Yr Bond Auction Coupon…

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Total Amount data reported »

30-Yr Bond Auction Total…

INSG

Inseego

$7.67

0.24 (3.23%)

13:05
12/12/19
12/12
13:05
12/12/19
13:05
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.16

1.675 (48.06%)

13:00
12/12/19
12/12
13:00
12/12/19
13:00
Recommendations
Amneal Pharmaceuticals analyst commentary  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$219.47

-0.59 (-0.27%)

, PTI

Proteostasis

$4.01

-0.23 (-5.42%)

12:55
12/12/19
12/12
12:55
12/12/19
12:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

VRTX

Vertex

$219.47

-0.59 (-0.27%)

PTI

Proteostasis

$4.01

-0.23 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Mar

ADBE

Adobe

$304.30

0.55 (0.18%)

, AVGO

Broadcom

$324.00

4.14 (1.29%)

12:53
12/12/19
12/12
12:53
12/12/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$304.30

0.55 (0.18%)

AVGO

Broadcom

$324.00

4.14 (1.29%)

COST

Costco

$295.82

0.6 (0.20%)

ORCL

Oracle

$56.16

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 23

    Jan

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
U.S. Household net worth rose »

U.S. Household net worth…

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
Treasury Action: yields remain near their highs of the sessio »

Treasury Action: yields…

CC

Chemours

$17.55

0.955 (5.75%)

12:45
12/12/19
12/12
12:45
12/12/19
12:45
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:41
12/12/19
12/12
12:41
12/12/19
12:41
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

12:36
12/12/19
12/12
12:36
12/12/19
12:36
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.